Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2024 06:00 ET | Source: Brains Bioceutical Corp

Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division

VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterinary Health...
August 21, 2023 07:20 ET | Source: Zion Market Research

Global Synthetic Cannabinoids Market Size Revenue Forecasted to Surpass $12.4 Billion by 2030, At a CAGR of 21.81%

New York, NY, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Synthetic Cannabinoids Market By Indication (Nausea/Vomiting, Pain Management, And...
March 15, 2021 18:40 ET | Source: Avicanna Inc.

NOTICE TO DISREGARD -- Avicanna Inc.

TORONTO, March 15, 2021 (GLOBE NEWSWIRE) -- We are advised by Avicanna Inc. that journalists and other readers should disregard the news release, “Avicanna to present at the Q1 Virtual Investor...
July 23, 2020 08:00 ET | Source: Ecofibre

UPDATE: ECOFIBRE LIMITED – Ananda Health products used in first clinical trial on hemp-derived CBD to treat chemotherapy-induced peripheral neuropathy

Georgetown, Kentucky, July 23, 2020 (GLOBE NEWSWIRE) -- Ecofibre Limited (Ecofibre, Company) (ASX:EOF, OTC-NASDAQ Intl Designation: EOFBF) is pleased to announce that the Lankenau Institute for...
July 07, 2020 08:58 ET | Source: Ecofibre

ECOFIBRE LIMITED – Ananda Health products used in first FDA authorized clinical trial on hemp-derived CBD to treat chemotherapy induced peripheral neuropathy

Georgetown, Kentucky, July 07, 2020 (GLOBE NEWSWIRE) -- Ecofibre Limited (Ecofibre, Company) (ASX:EOF, OTC-NASDAQ Intl Designation: EOFBF) is pleased to announce that the Lankenau Institute for...